Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 6MMR | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 | |
| 6MMG | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | |
| 6MMG | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | |
| 6MMN | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 | |
| 6MMN | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 | |
| 6MMP | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 | |
| 6MMP | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 | |
| 6MML | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
| 6MML | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
| 6MMK | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
| 6MMK | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | |
| 6MM9 | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 | |
| 6MM9 | Q00959 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 | |
| 7V1X | A0A6L9SN29 | Difructose dianhydride I synthase/hydrolase (alphaFFase1) from Bifidobacterium dentium in complex with beta-D-fructofuranose | |
| 7V1W | A0A6L9SN29 | Difructose dianhydride I synthase/hydrolase (alphaFFase1) from Bifidobacterium dentium in complex with beta-D-arabinofuranose | |
| 4TW9 | P48730 | Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation | |
| 4AZ7 | P49610 | Differential inhibition of the tandem GH20 catalytic modules in the pneumococcal exo-beta-D-N-acetylglucosaminidase, StrH | |
| 4AZH | P49610 | Differential inhibition of the tandem GH20 catalytic modules in the pneumococcal exo-beta-D-N-acetylglucosaminidase, StrH | |
| 1N04 | P02789 | Diferric chicken serum transferrin at 2.8 A resolution. | |
| 3QYT | P02787 | Diferric bound human serum transferrin | |
| 1XLW | P06276 | Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate | |
| 4ZZP | F0ZJZ1 | Dictyostelium purpureum cellobiohydrolase Cel7A apo structure | |
| 4ZZQ | Q55FE6 | Dictyostelium discoideum cellobiohydrolase Cel7A apo structure | |
| 5MTY | Q16539 | Dibenzosuberone inhibitor 8e in complex with p38 MAPK | |
| 5MTX | Q16539 | Dibenzooxepinone inhibitor 12b in complex with p38 MAPK | |
| 2LHX | 2LHX | Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat | |
| 2LHY | 2LHY | Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat | |
| 2LHZ | 2LHZ | Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat | |
| 1OGO | P48845 | Dex49A from Penicillium minioluteum complex with isomaltose | |
| 5A6M | A3DJS9 | Determining the specificities of the catalytic site from the very high resolution structure of the thermostable glucuronoxylan endo-Beta-1, 4-xylanase, CtXyn30A, from Clostridium thermocellum with a xylotetraose bound | |
| 7UWP | L8GJB3 | Detergent-bound CYP51 from Acanthamoeba castellanii | |
| 2ALU | P24627 | Detection of new binding site in the C-terminal lobe of lactoferrin:Crystal structure of the complex formed between bovine lactoferrin and a tetrasaccharide at 2.1A resolution | |
| 6NE2 | O75084 | Designed repeat protein in complex with Fz7 | |
| 6NE2 | 6NE2 | Designed repeat protein in complex with Fz7 | |
| 6NE1 | Q9ULV1 | Designed repeat protein in complex with Fz4 | |
| 6NE1 | 6NE1 | Designed repeat protein in complex with Fz4 | |
| 1Y4C | P02928 | Designed Helical Protein fusion MBP | |
| 1NO9 | P00734 | Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies. | |
| 1NO9 | P28501 | Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies. | |
| 1NA0 | 1NA0 | Design of Stable alpha-Helical Arrays from an Idealized TPR Motif | |
| 1NA3 | 1NA3 | Design of Stable alpha-Helical Arrays from an Idealized TPR Motif | |
| 3OAD | P00797 | Design and optimization of new piperidines as renin inhibitors | |
| 3OAG | P00797 | Design and optimization of new piperidines as renin inhibitors | |
| 3O9L | P00797 | Design and optimisation of new piperidines as renin inhibitors | |
| 3G6Z | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 3G70 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 3G72 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | |
| 4O6B | P29990 | Dengue Type2 Virus Non-structural protein 1 (NS1) Form 1 crystal | |
| 8CII | 8CII | Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody | |
| 8CII | P0DTC2 | Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody |
